Avantor (AVTR) Stock Forecast & Price Target

Compare

467 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

AVTR Analyst Ratings

Hold

2 Buy

8 Hold

2 Sell

Based on 12 analysts giving stock ratings to

Avantor

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

AVTR Stock 12 Month Forecast

Average Price Target

$10.36

▲(30.64% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Avantor in the last 3 months. The average price target is $10.36 with a high forecast of $14.00 and a low forecast of $8.00. The average price target represents a 30.64% change from the last price of $7.93.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","12":"$12","17":"$17","9.5":"$9.5","14.5":"$14.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$14.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.36,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$10.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,9.5,12,14.5,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.81,9.20923076923077,9.608461538461539,10.007692307692308,10.406923076923077,10.806153846153846,11.205384615384617,11.604615384615386,12.003846153846155,12.403076923076924,12.802307692307693,13.201538461538462,13.600769230769231,{"y":14,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.81,8.92923076923077,9.048461538461538,9.167692307692308,9.286923076923078,9.406153846153845,9.525384615384615,9.644615384615385,9.763846153846155,9.883076923076922,10.002307692307692,10.121538461538462,10.24076923076923,{"y":10.36,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.81,8.747692307692308,8.685384615384615,8.623076923076923,8.560769230769232,8.49846153846154,8.436153846153847,8.373846153846154,8.311538461538461,8.249230769230769,8.186923076923076,8.124615384615385,8.062307692307693,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.7,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.8,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.96,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.92,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.36,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.29,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 40, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.67,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 51, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.82,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 39, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.75,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 42, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.46,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":11.07,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 42, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":8.81,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$14.00

Average Price Target$10.36

Lowest Price Target$8.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Luke Sergott

Barclays

$9→$8.5

Sell

7.19%

Upside

Downgraded

03/06/26

Avantor downgraded to Underweight from Equal Weight at BarclaysAvantor downgraded to Underweight from Equal Weight at Barclays

Brandon Couillard

Wells Fargo

$16→$14

Buy

76.54%

Upside

Reiterated

02/13/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Avantor (NYSE: AVTR) and Moderna (NASDAQ: MRNA)

Kallum Titchmarsh

Morgan Stanley

$12→$10

Hold

26.10%

Upside

Reiterated

02/13/26

Morgan Stanley Sticks to Their Hold Rating for Avantor (AVTR)

Daniel Brennan

TD Cowen

$12→$10

Hold

26.10%

Upside

Reiterated

02/12/26

Avantor: Elevated Execution Risk and Limited Visibility Justify Hold and Wait‑and‑See Stance

Catherine Ramsey Schulte

Robert W. Baird

$15→$11

Buy

38.71%

Upside

Reiterated

02/12/26

Avantor price target lowered to $11 from $15 at BairdAvantor price target lowered to $11 from $15 at Baird

Dan Leonard

UBS

$13→$10.5

Hold

32.41%

Upside

Reiterated

02/12/26

Avantor price target lowered to $10.50 from $13 at UBSAvantor price target lowered to $10.50 from $13 at UBS

Tycho Peterson

Jefferies

Sell

0.88%

Upside

Reiterated

02/12/26

Avantor price target lowered to $8 from $9 at JefferiesAvantor price target lowered to $8 from $9 at Jefferies

Patrick B Donnelly

Citi

$13→$11

Hold

38.71%

Upside

Reiterated

02/12/26

Avantor: Subdued Outlook and Execution Risks Justify Hold Rating and Trimmed Target Price

Daniel Arias

Stifel Nicolaus

$12→$10

Hold

26.10%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Inspire Medical Systems (NYSE: INSP) and Avantor (NYSE: AVTR)

Matt Larew

William Blair

―

Hold

―

Assigned

02/12/26

Analysts Offer Insights on Healthcare Companies: Glaukos (NYSE: GKOS) and Avantor (NYSE: AVTR)

Michael Ryskin

Bank of America Securities

$13→$11

Hold

38.71%

Upside

Reiterated

02/11/26

Avantor price target lowered to $11 from $13 at BofAAvantor price target lowered to $11 from $13 at BofA

Vijay Kumar

Evercore ISI

$12→$10

Hold

26.10%

Upside

Reiterated

02/11/26

Avantor: Top-Line Weakness, Margin Pressure, and Macro Uncertainty Justify Balanced Hold Rating

Unknown Analyst

Nephron

Not Ranked

Nephron

Sell

0.88%

Upside

Downgraded

12/11/25

Avantor downgraded to Sell from Hold at Nephron ResearchAvantor downgraded to Sell from Hold at Nephron Research

Andrew Cooper

Raymond James

―

Hold

―

Downgraded

11/04/25

Avantor downgraded to Market Perform from Outperform at Raymond JamesAvantor downgraded to Market Perform from Outperform at Raymond James

Casey Woodring

J.P. Morgan

$14→$12

Hold

51.32%

Upside

Downgraded

10/30/25

Avantor downgraded to Neutral from Overweight at JPMorganAvantor downgraded to Neutral from Overweight at JPMorgan

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Luke Sergott

Barclays

$9→$8.5

Sell

7.19%

Upside

Downgraded

03/06/26

Avantor downgraded to Underweight from Equal Weight at BarclaysAvantor downgraded to Underweight from Equal Weight at Barclays

Brandon Couillard

Wells Fargo

$16→$14

Buy

76.54%

Upside

Reiterated

02/13/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Avantor (NYSE: AVTR) and Moderna (NASDAQ: MRNA)

Kallum Titchmarsh

Morgan Stanley

$12→$10

Hold

26.10%

Upside

Reiterated

02/13/26

Morgan Stanley Sticks to Their Hold Rating for Avantor (AVTR)

Daniel Brennan

TD Cowen

$12→$10

Hold

26.10%

Upside

Reiterated

02/12/26

Avantor: Elevated Execution Risk and Limited Visibility Justify Hold and Wait‑and‑See Stance

Catherine Ramsey Schulte

Robert W. Baird

$15→$11

Buy

38.71%

Upside

Reiterated

02/12/26

Avantor price target lowered to $11 from $15 at BairdAvantor price target lowered to $11 from $15 at Baird

Dan Leonard

UBS

$13→$10.5

Hold

32.41%

Upside

Reiterated

02/12/26

Avantor price target lowered to $10.50 from $13 at UBSAvantor price target lowered to $10.50 from $13 at UBS

Tycho Peterson

Jefferies

Sell

0.88%

Upside

Reiterated

02/12/26

Avantor price target lowered to $8 from $9 at JefferiesAvantor price target lowered to $8 from $9 at Jefferies

Patrick B Donnelly

Citi

$13→$11

Hold

38.71%

Upside

Reiterated

02/12/26

Avantor: Subdued Outlook and Execution Risks Justify Hold Rating and Trimmed Target Price

Daniel Arias

Stifel Nicolaus

$12→$10

Hold

26.10%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Inspire Medical Systems (NYSE: INSP) and Avantor (NYSE: AVTR)

Matt Larew

William Blair

―

Hold

―

Assigned

02/12/26

Analysts Offer Insights on Healthcare Companies: Glaukos (NYSE: GKOS) and Avantor (NYSE: AVTR)

Michael Ryskin

Bank of America Securities

$13→$11

Hold

38.71%

Upside

Reiterated

02/11/26

Avantor price target lowered to $11 from $13 at BofAAvantor price target lowered to $11 from $13 at BofA

Vijay Kumar

Evercore ISI

$12→$10

Hold

26.10%

Upside

Reiterated

02/11/26

Avantor: Top-Line Weakness, Margin Pressure, and Macro Uncertainty Justify Balanced Hold Rating

Unknown Analyst

Nephron

Not Ranked

Nephron

Sell

0.88%

Upside

Downgraded

12/11/25

Avantor downgraded to Sell from Hold at Nephron ResearchAvantor downgraded to Sell from Hold at Nephron Research

Andrew Cooper

Raymond James

―

Hold

―

Downgraded

11/04/25

Avantor downgraded to Market Perform from Outperform at Raymond JamesAvantor downgraded to Market Perform from Outperform at Raymond James

Casey Woodring

J.P. Morgan

$14→$12

Hold

51.32%

Upside

Downgraded

10/30/25

Avantor downgraded to Neutral from Overweight at JPMorganAvantor downgraded to Neutral from Overweight at JPMorgan

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Avantor

3 Months

xxx

Success Rate

11/20 ratings generated profit

Average Return

-2.10%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 55.00% of your transactions generating a profit, with an average return of -2.10% per trade.

1 Year

Luke SergottBarclays

Success Rate

10/31 ratings generated profit

Average Return

-15.15%

downgraded a sell rating 10 days ago

Copying Luke Sergott's trades and holding each position for 1 Year would result in 32.26% of your transactions generating a profit, with an average return of -15.15% per trade.

2 Years

xxx

Success Rate

2/17 ratings generated profit

Average Return

-22.74%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 11.76% of your transactions generating a profit, with an average return of -22.74% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AVTR Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, AVTR has received 2 Buy Ratings, 30 Hold Ratings, and 2 Sell Ratings. AVTR average Analyst price target in the past 3 months is 10.36.

Each month's total comprises the sum of three months' worth of ratings.

AVTR Financial Forecast

AVTR Earnings Forecast

Next quarter’s earnings estimate for AVTR is $0.16 with a range of $0.15 to $0.16. The previous quarter’s EPS was $0.22. AVTR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year AVTR has Performed in-line its overall industry.

AVTR Sales Forecast

Next quarter’s sales forecast for AVTR is $1.55B with a range of $1.52B to $1.61B. The previous quarter’s sales results were $1.66B. AVTR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year AVTR has Performed in-line its overall industry.

AVTR Stock Forecast FAQ

What is AVTR’s average 12-month price target, according to analysts?

Based on analyst ratings, Avantor Inc’s 12-month average price target is 10.36.

What is AVTR’s upside potential, based on the analysts’ average price target?

Avantor Inc has 30.64% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is AVTR a Buy, Sell or Hold?

Avantor Inc has a consensus rating of Hold which is based on 2 buy ratings, 8 hold ratings and 2 sell ratings.

What is Avantor Inc’s price target?

The average price target for Avantor Inc is 10.36. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $14.00 ,the lowest forecast is $8.00. The average price target represents 30.64% Increase from the current price of $7.93.

What do analysts say about Avantor Inc?

Avantor Inc’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of AVTR?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Avantor (AVTR) Stock Forecast & Price Target

AVTR Analyst Ratings

AVTR Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Avantor

AVTR Analyst Recommendation Trends

AVTR Financial Forecast

AVTR Earnings Forecast

AVTR Sales Forecast

AVTR Stock Forecast FAQ

Detailed List of Analyst Forecasts